Skip to main content

Table 2 Number of cohorts, offspring, and NMR-derived metabolic traits included in each life course stage analysis

From: Effect of common pregnancy and perinatal complications on offspring metabolic traits across the life course: a multi-cohort study

Age category

Pregnancy and perinatal complications

PE

GH

GD

PTB

SGA

LGA

Neonatea

 N-exposed/total (N-cohorts/traits)

89/3117 (2/76)

192/3120 (2/76)

223/1896 (2/76)

201/3225 (2/76)

227/2998 (2/76)

226/2997 (2/76)

Infancyb

 N-exposed/total (N-cohorts/traits)

53/1894 (2/135)

101/1897 (2/135)

135/1181 (2/135)

156/1963 (2/135)

141/1831 (2/135)

132/1822 (2/135)

Childhoodc

 N-exposed/total (N-cohorts/traits)

130/6883 (2/148)

910/6774 (2/148)

45/6806 (2/148)

350/6908 (2/148)

331/6144 (2/148)

664/6447 (2/148)

Adolescenced

 N-exposed/total (N-cohorts/traits)

134/6117 (2/162)

538/7012 (3/162)

57/3320 (2/162)

429/7947 (3/162)

466/7137 (3/162)

943/7614 (3/162)

Adulthoode

 N-exposed/total (N-cohorts/traits)

154/5850 (3/156)

760/4135 (3/156)

50/2857 (2/156)

441/8925 (4/155)

313/6387 (2/160)

652/6727 (2/160)

  1. PE pre-eclampsia, GH gestational hypertension, GD gestational diabetes, PTB preterm birth, SGA small for gestational age, LGA large for gestational age
  2. a Metabolic traits were assessed in cord blood in the BiB cohort (n=2499 offspring) and the BIS cohort (n=726 offspring)
  3. b NMR-derived metabolic traits were assessed at mean age 1.1 years (SD=0.1) in the BIS cohort (n=591) and at mean age 1.6 years (standard deviation (SD)=0.5) in the BiB cohort (n=1373)
  4. c NMR-derived metabolic traits were assessed at mean age 4.2 years (SD=0.3) in the BIS cohort (n=429) and at mean age 7.5 years (SD=0.2) in the ALSPAC cohort (n=6206)
  5. d NMR-derived metabolic traits were assessed at mean age 12.0 years (SD=0.4) in the CheckPoint cohort (n=898), at mean age 15.4 years (SD=0.3) in the ALSPAC cohort (n=2348), and at mean age 16.0 years (SD=0.4) in the NFBC1986 cohort (n=4614)
  6. e NMR-derived metabolic traits were assessed at mean age 22.0 years (SD=7.0) in the YFS cohort (SD=n=509), at mean age 24.5 years (SD=0.8) in the ALSPAC cohort (n=2256), at mean age 46.6 years (SD=0.6) in the NFBC1966 cohort (n=5137), and at mean age 67.8 years (SD=4.4) in the HBCS cohort (n=1057). Adult meta-analysis was done using NFBC1966 age 46.6 years results because of the bigger sample size at this; meta-analysis results did not differ when repeated using NFBC1966 age 31.2 years and so only the age 46 results are included